Comparative effects of cilostazol and aspirin on the impairment of endothelium-dependent cerebral vasodilation caused by acute cigarette smoking in rats

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 4, 2010, Pages 483-488

  Iida, Hiroki ^a   Iida, Mami ^a   Takenaka, Motoyasu ^a   Fukuoka, Naokazu ^a   Dohi, Shuji ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Aspirin; Cilostazol; Endothelial dysfunction; Rat; Smoking; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; ACETYLCHOLINE; CARBOXYMETHYLCELLULOSE; CHOLINERGIC RECEPTOR STIMULATING AGENT; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOLE; ARTERY ENDOTHELIUM; ARTICLE; BRAIN ARTERY; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; IN VIVO STUDY; MALE; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION; ANIMAL; CEREBELLUM; COMPARATIVE STUDY; HUMAN; PATHOPHYSIOLOGY; SMOKING; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ACETYLCHOLINE; ANIMALS; ASPIRIN; CARBOXYMETHYLCELLULOSE; CEREBELLUM; CEREBRAL ARTERIES; CHOLINERGIC AGENTS; CYCLOOXYGENASE INHIBITORS; ENDOTHELIUM, VASCULAR; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SMOKING; TETRAZOLES; VASODILATION;

EID: 77955485577     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0382-7     Document Type: Article

References (29)

1. Wolf PA, D'Agostino RB, Kannel WB et al (1988) Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 259:1025-1029
2. Mannami T, Iso H, Baba S et al (2004) Cigarette smoking and risk of stroke and its subtypes among middle-aged Japanese men and women: the JPHC study cohort I. Stroke 35:1248-1253 (Pubitemid 38697436)
3. Ovbiagele B, Weir CJ, Saver JL et al (2006) Effect of smoking status on outcome after acute ischemic stroke. Cerebrovasc Dis 21:260-265
4. Celermajer DS, Sorensen KE, Georgakopoulos D et al (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88:2149-2155
5. Heitzer T, Yla-Herttuala S, Luoma J et al (1996) Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation 93:1346-1353
6. Fang Q, Sun H, Mayhan WG (2003) Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol 284: H528-H534 (Pubitemid 36142879)
7. Iida H, Iida M, Takenaka M et al (2006) Angiotensin II type 1 (AT1)-receptor blocker prevents impairment of endotheliumdependent cerebral vasodilation by acute cigarette smoking in rats. Life Sci 78:1310-1316
8. Iida H, Iida M, Takenaka M et al (2008) Rho-kinase inhibitor and nicotinamide adenine dinucleotide phosphate oxidase inhibitor prevent impairment of endothelium-dependent cerebral vasodilation by acute cigarette smoking in rats. J Renin Angiotensin Aldosterone Syst 9:89-94
9. Liao JK (2007) Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer? Circulation 115:1615-1621
10. Huang Y, Cheng Y, Wu J et al (2008) Cilostazol as an alternative to aspirin after ischaemic stroke: a randomized, double-blind, pilot study. Lancet Neurol 7:494-499
11. Oida K, Ebata K, Kanehara H et al (2003) Effect of cilostazol on impaired vasodilatory response of the brachial artery to ischemia in smokers. J Atheroscler Thromb 10:93-98
12. Hashimoto A, Miyakoda G, Hirose Y, Mori T (2006) Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A-and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 189:350-357
13. Park SY, Lee JH, Kim CD et al (2006) Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation. J Pharmacol Exp Ther 317:1238-1245
14. Iba T, Kidokoro A, Fukunaga M et al (2006) Comparison of the protective effects of type III phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice. Shock 26:522-526
15. Noon JP, Walker BR, Hand MF, Webb DJ (1998) Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. Cardiovasc Res 38:480-484
16. Deng S, Deng PY, Jiang JL et al (2004) Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats. Acta Pharmacol Sin 25:1633-1639
17. Ishizuka T, Niwa A, Tabuchi M et al (2008) Acetylsalicylic acid provides cerebrovascular protection from oxidant damage in saltloaded stroke-prone rats. Life Sci 82:806-815
18. Iida M, Iida H, Dohi S et al (1998) Mechanisms underlying cerebrovascular effects of cigarette smoking in rats in vivo. Stroke 29:1656-1665
19. Matsumoto M (2005) Cilostazol in secondary prevention of stroke: impact of the cilostazol stroke prevention study. Atheroscler Suppl 6:33-40
20. Nakamura T, Houchi H, Minami A et al (2001) Endotheliumdependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta. Life Sci 69:1709-1715
21. Ito H, Miyakoda G, Mori T (2004) Cilostazol inhibits plateletleukocyte interaction by suppression of platelet activation. Platelets 15:293-301
22. Madajka M, Korda M, White J, Malinski T (2003) Effect of aspirin on constitutive nitric oxide synthase and the biovailability of NO. Thromb Res 110:317-321
23. Gresele P, Migliacci R, Procacci A et al (2007) Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication. Thromb Haemost 97:444-450
24. Watanabe K, Ikeda S, Komatsu J et al (2003) Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris. Am J Cardiol 92:21-25
25. Bilgen I, Oner G, Eren E (2003) Dietary L-arginine restores aspirin-induced endothelial dysfunction in rat aorta. Arch Physiol Biochem 111:232-238
26. Akiyama H, Kudo S, Shimizu T (1985) The absorption, distribution and excretion of a new antithrombotic and vasodilating agent, cilostazol, in rat, rabbit, dog and man. Arzneimittelforschung 35:1124-1132
27. Akiyama H, Kudo S, Shimizu T (1985) The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man. Arzneimittelforschung 35:1133-1140
28. Nonaka Y, Koumura A, Hyakkoku K et al (2009) Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone. J Pharmacol Exp Ther 330:13-22
29. Choi JM, Shin HK, Kim KY et al (2002) Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther 300:787-793